Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation
Clinical trial NCT00659334 · TERMINATED
Trial details
- NCT number
- NCT00659334
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2010-03-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.